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Abstract 
 
Purpose: To estimate the risk of lower gastro-intestinal bleeding (LGIB) caused by 
malignant lesion in patients presenting with per-rectal bleeding (PRB), by using visual 
aid as an objective measurement of PRB colour.  
 
Methods: This was a prospective observational study on patients presented with PRB 
to Family Medicine Specialty Clinic, who undergo flexible sigmoidoscopy (FS) or 
colonoscopy (CLN) from December 2012 to September 2013. Patients aged 40 years 
old or above, haemodynamically stable, with normal haemoglobin level were included. 
Patients with history of previous colonic surgery, refused to have FS or CLN, with 
ophthalmologic diseases such as colour blindness were excluded. Parameters 
including subjective description of PRB colour, number of chosen red colour by 
patients, source and distance of bleeding from anal verge were recorded for analysis. 
Receiver operating characteristic (ROC) curve was used to identify the optimal cutoff 
level of colour for diagnosing colonic lesion. Diagnostic accuracy was assessed by 
area under the ROC curve (AUC). Accountability of this model was assessed by 
logistic regression.  
 
Results: The dark PRB colour was associated with diagnosis of tumour (p<0.001) and 
advanced neoplastic polyp (p<0.001). The light PRB colour was associated with the 
diagnosis of piles (p<0.001). The performance of our model to predict tumour or 
advanced neoplastic polyps by colour (AUC: 0.798) had a better discriminative power 
than that to predict colonic lesion alone (AUC: 0.610) by ROC curve analysis. 
 
Conclusion: Objective measurement of PRB colour accurately estimated the risk of 
LGIB caused by malignant lesion in patients presenting with PRB.  
 
Keywords: lower gastro-intestinal bleeding; per rectal bleeding; colour cards; 
colonoscopy; sigmoidoscopy. 
 
What does this paper add to the literature? 
Objective measurement of per-rectal bleeding colour is a valid and non-invasive tool 
for estimating the risk of lower gastro-intestinal bleeding caused by malignant lesion. 
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Manuscript Text 
Introduction 
 
Per-rectal bleeding (PRB) is a common presentation in primary care. (1)  Although 
most cases of PRB are due to local conditions like haemorrhoids and many other 
non-malignant conditions, this symptom is a major sign of colorectal cancer and is 
frequently the first presenting symptom. (2-5) 
 
The physician’s interrogation of the patient for a description of PRB is the standard 
initial approach to diagnosing lower gastro-intestinal bleeding (LGIB). (6, 7)  And 
yet, this subjective clinical approach had not been tested or validated in primary care.  
There are variability and inconsistency in subjective colour reporting by patients.  It 
is worthy to verify patients’ subjective description by an objective visual aid.   
 
From the literature review, the appearance of the passed blood could be dependent on 
two factors. The first is the length of time in the intestine. (7) It shows that the 
darkness of the red colour of PRB is related to the distance from the anal verge.   
The second is the proportion of oxygenated blood: deoxygenated blood. It is because 
arterial blood contains oxygenated blood which is lighter in colour while venous 
blood contains deoxygenated blood which is darker in colour. (8,9) Therefore, the 
objective PRB colour can help to correlate the cause and site of LGIB.  
 
As PRB is a common clinical problem, there is a large and increasing demand of both 
flexible sigmoidoscopy (FS) and colonoscopy (CLN).  Due to limitation in health 
resources, the waiting list of FS and CLN in public health sector is quite long. It is 
important to decide which patients with PRB need either FS or CLN most so that we 
can pick up those high risk cases of colorectal cancer for early investigation. (10-14) 
 
This study aimed at estimating the risk of LGIB caused by malignant lesion in 
patients presenting with PRB by an objective measurement of the colour of PRB so 
that we can identify which patient with PRB needs flexible sigmoidoscopy or 
colonoscopy earlier. Another aim was to use visual aid to assist in history taking for 
the description of colour of PRB, so that we can have a more objective assessment of 
the colour of PRB.  
 
Method 
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 4 
This was a prospective observational study on patients presented with PRB to the 
Family Medicine Specialty Clinic (FMSC) in Hong Kong and those who underwent 
flexible sigmoidoscopy or colonoscopy subsequently during the period from 
December 2012 to September 2013.   
 
Patients who were aged 40 or older, haemodynamically stable, with normal 
haemoglobin level were included. Patients were excluded if they had history of 
previous colonic resections or surgical alterations, refused to have FS or CLN, had 
blindness or ophthalmologic diseases such as colour blindness which affect the 
differentiation of colour.  
 
Procedure 
 
Before FS or CLN, complete blood pictures were done to make sure that they were 
not anaemic due to massive blood loss. It was because massive bleeding may affect 
the transit time of the blood in the intestine and then affect the colour of the blood in 
the stool. Blood pressure and pulse were checked to ensure that the patients were 
haemodynamically stable. All subjects were asked to describe in words the colour of 
PRB.  Patients were free to use their own terms without any direction from the 
physician. After that, the patients were shown by the physician a colour card (Figure 1) 
composing of four numbered colours from the left of brightest red to the right of 
darkest red and were invited to point to a specific colour that was best approximate to 
the colour of the PRB.  The choices were recorded as a colour number ranging from 
1 to 4. Either FS or CLN would be performed by endoscopist to find out the site and 
source of LGIB. 
 
The parameters including the subjective description of PRB colour, the number of the 
chosen red colour from the card by the patient, the source of bleeding and the distance 
from the anal verge to the causative lesion found in FS or CLN, were all recorded for 
outcome analysis. Research ethics of this study was approved by the Kowloon West 
Cluster Research Ethics Committee, Hong Kong.  
 
Data Analysis  
 
Descriptive statistics were presented with median and interquartile range for 
continuous variables, and frequency and proportion for categorical variables 
Differences in patients’ characteristics between the PRB colour were tested using 
Chi-square test or Mann-Whitney U-test, where appropriate.  
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Accuracy in terms of the sensitivity, specificity, positive predictive value (PPV) and 
negative predictive value (NPV) of the use of PRB colour in diagnosing colonic 
lesions (polyp or tumour), or diagnosing ominous colonic lesion (tumour or advanced 
neoplastic polyps), as well as tumour alone, were compared to diagnosis confirmed by 
FS or CLN as the diagnostic standard. The receiver operating characteristic (ROC) 
curve would be obtained by plotting sensitivity against (1-specificity) for each cutoff 
value for identification of the optimal cutoff level of PRB colour for diagnosing 
colonic lesion or tumour among this population compared to diagnosis confirmed by 
FS or CLN. Diagnostic accuracy was assessed by the area under the ROC curve 
(AUC). The accountability of this model was assessed by logistic regression analysis, 
accounting for all other clinical and socio-demographic characteristics. Finally, 
predicted probabilities of diagnosing colonic lesion outcomes were estimated with 
respect to the PRB colour. 
 
All data analyses were conducting SPSS Version 21.0. P-value of <0.05 was 
considered as statistical significance. 
 
Sample Size 
 
The sample size required was estimated by two parameters: prevalence of PRB and 
odds ratio. The prevalence of PRB was estimated as 14.7% in Turkish population. 
Since there was no literature showing the prevalence of PRB in Hong Kong, and 
Turkish as an Asian population, we used it to calculate our study sample size. Given 
an estimate of prevalence rate in Turkey from previous study, sample size of 283 
subjects was large enough to detect an odds ratio of 1.6 with 80% power at the 0.05 
significance level with a two-sided test. By assuming 87.3% of colonoscopy 
attendance rate we needed 325 subjects in total. (15-17) 
 
Results 
 
A total of 325 eligible patients were consented to join the study.  Amongst them, 293 
patients were completed with either FS or CLN. 32 patients were lost to follow up due 
to the default of endoscopy appointment. In this study, the majority of patients 
presented with PRB were male. The gender, smoking status, complaints of change of 
the bowel habit, change of the stool and procedure were more frequently associated 
with change of colour in PRB. (Table 1) The other demographic and clinical 
characteristics of our patients did not vary significantly between different colour 
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groups. The dark colour change of the PRB was statistically significant associated 
with diagnosis of tumour (p<0.001) and advanced neoplastic polyp (p<0.001) in our 
study. (Table 2) On the other hand, the light colour change of PRB was statistically 
significant associated with the diagnosis of piles (p<0.001). The other benign lesions 
like colonitis, proctitis, anal fissure did not vary significantly between different colour 
groups. The colour change of the PRB was also significantly associated with the 
distance of the lesion from the anal verge. The light red colour was significantly 
associated with the site of rectum and the dark red colour was associated significantly 
with the transverse colon, but not the other sites of the colon. (Table 2)  
 
When the demographic, clinical and diagnostic factors were further adjusted in the 
logistic regression model, the diagnosis of polyps or tumour were more significantly 
associated with the darker colour change of PRB (Colour ≥2), and diagnosis of 
malignant lesions like tumour or advanced neoplastic polyps were more significantly 
with a trend towards the darkest colour change of PRB (Colour 3 & 4). In other words, 
the light PRB colour (Colour 1) had higher likelihood of neither polyp nor tumour. 
The performance of our model to predict tumour or advanced neoplastic polyps by the 
change of colour of PRB had a better discriminative power than that to predict colonic 
lesion alone by ROC curve analysis (Table 3 & 4, figure 2-4).  
 
Predicted probability of colonic lesion was gradually increased with the darker colour 
of PRB (Figure 1). Colour 4 indicated the predicted probability of 86.6% for any 
colonic lesion, 60.9% for ominous colonic lesion, and 34.5% for tumour. 
 
Discussion 
 
PRB is a common presenting symptom of colorectal cancer, though most cases of 
PRB encountered in primary care are due to local benign causes, such as piles. 
However, a useful tool is still lacking for the family physician to predict the benign 
causes from the malignant causes and to prioritize the patients for further invasive 
investigations like enemas or endoscopies. 
 
In clinical practice, it is common to perform FS or CLN in patients with bowel 
symptoms because of the concern about colorectal cancer. (10,18)  Change of bowel 
habit and PRB are significantly associated with left-sided cancers. (10,12)  In Choi 
et al, it reported that FS was a valuable initial investigation for patients older than 40 
years presenting with bright red PRB without other bowel symptoms instead of 
colonoscopy. (10)    
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Since PRB is a very common clinical problem in Hong Kong, the demand of both FS 
and CLN is ever increasing. The waiting lists of both FS and CLN in the public 
hospitals become longer and longer due to the limited health resources. It is important 
to differentiate those patients with PRB at high risks of colorectal cancer for early 
investigations. (10-14)  
 
PRB represents a diverse range of bleeding sources and severities, ranging from 
haemorrhoidal bleeding to blood loss from colorectal tumours.(19) The described 
colouration of PRB by patients is frequently transposed to medical terminology by 
physicians. (7) Various terms are used to describe blood emanating from the lower 
gastrointestinal tract, including hematochezia, rectal bleeding and bright red blood 
per-rectum. These terms, even when defined, are somewhat non-specific and do not 
indicate the acuity or severity of bleeding and do not always localize the bleeding 
sources. (19)  When PRB is not witnessed by the physicians, they usually rely on the 
patients’ description of the blood colour (7) e.g. ‘bright red’, ‘light red’, ‘dark-red’, 
‘brown’, etc.  Again, these subjective descriptions of colour had not been tested in 
any systemic fashion in our locality and in primary care. (6,7) 
 
In a study done by Zuckerman GR et al (6), evaluated prospectively if an objective 
test of stool colour would correlate with or improve upon subjective descriptions in 
predicting bleeding locations. The objective test employed was a simple pocket sized 
card containing five numbered colours that typify the spectrum of stool colours.  
This study revealed marked variability and surprisingly inconsistency in subjective 
colour reporting for both patients and physicians and the superiority of several card 
colours for separating upper from lower bleeding sources. (7)  
 
Choi et al reported that flexible sigmoidoscopy was a valuable initial investigation for 
patients older than 40 years presenting with bright red PRB without other bowel 
symptoms. (10) However, the description of ‘bright red’ PRB was not standardized 
either.  Patients’ description may not be accurate but the darkness of the red colour of 
PRB may actually give us a clue on the site and source of bleeding in the distal lower 
intestinal tract.  The darkness of the colour of PRB may be helpful in the general 
evaluation of the level of bleeding, i.e. the distance of bleeding site from the anus. (6)  
Moreover, it may be related to the pathology of the bleeding. For example, 
haemorrhoidal bleeding may have a lighter red colour as haemorrhoids are 
arterio-venous shunts. (20) The arterial component made the red colour lighter as it 
contains oxygenated blood. (8) The mucus from malignant tumour may make the 
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 8 
PRB darker in colour.  Therefore, light red PRB may point to benign and distal 
lesion while dark red PRB may point to malignant and proximal lesion.  
 
Therefore, we would like to verify the validity of patient’s history on the PRB colour 
with an objective confirmation and try to find out the relationship between colour of 
PRB and the site and source of LGIB.  In our study, a colour card (Figure 1) 
containing four numbered colours (from bright red to dark red with RGB colour 
coding) was used.  These colours had been determined in a pilot study to 
approximate the spectrum of PRB colour most commonly reported by patients with 
PRB. 
 
Most of the previous studies focus on the acute LGIB in hospitalized patients.  The 
area is grossly under-explored in primary care, and yet it is very important in our daily 
practice. We need to identify the prediction of outcome of our patients with PRB upon 
their presentation with objective assessment so that we can decide which patients with 
PRB need FS or CLN most. 
 
In this study, we used the visual aid to assist in history taking for the description of 
colour of PRB, so that we could have a more objective assessment of the colour of the 
PRB. It was found to have a marked variability and inconsistency of the colour 
chosen from the card by patients in responding to their subjective description of the 
colour of the PRB. Despite most patients complained of “fresh PRB” chose colour 1 
& 2, some patients still chose colour 3 & 4 from the card. On the other hand, a few 
patients complained of dark coloured PRB, they chose colour 1 from the cards finally. 
(Table 6) These all reflect the facts that inconsistency between subjective and 
objective assessment in history taking and a more accurate objective method is needed 
for a better and more consistent communication between the patient and the physician. 
Accurate and good history taking is certainly the first step in making the right 
diagnosis. 
 
Furthermore, the objective measurement of the colour of the PRB can help estimating 
the risk of LGIB caused by malignant lesion in patients presenting with PRB, after 
adjusting for demographic, clinical and diagnostic factors. In this study, it is shown 
that the darker coloured PRB had higher likelihood of predicting colonic polyp or 
tumour. On the other hand, the lighter coloured PRB like colour 1 had higher 
likelihood of predicting neither polyp nor tumour. This result is very helpful in our 
clinical practice, not only for the family physicians, but also for the surgeons. We can 
use this assessment model to identify which patient with PRB needs endoscopy earlier, 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 9 
so that we can make better use of our limited health resources in the public health 
sector. In addition, the colour change of the PRB is also significantly associated with 
the distance of the colonic lesion from the anal verge. Therefore, the visual aid colour 
scheme can be a useful tool for triaging those high risk patients with PRB for either 
flexible sigmoidoscopy or colonoscopy, in order to make economic use of the 
endoscopic investigations. 
 
Hence, a suggested treatment algorithm is formulated (figure 5). Patients presented 
with PRB are instructed to choose a colour from the colour card that is best 
approximate to the colour of the PRB. If colour 3 or 4 is chosen, early CLN should be 
arranged as soon as possible. On the other hand, if colour 1 or 2 is chosen, routine 
CLN can be arranged. However, for patients with previous CLN and have been 
diagnosed to have benign conditions, e.g. haemorrhoids, they could be observed with 
regular follow up. During each follow up, they are instructed to choose a colour from 
the colour card again, according to the colour of the PRB. The choice of colour should 
be monitored closely during each visit. Early CLN should be arranged promptly if the 
patients choose colour 3 or 4. 
 
Conclusion 
 
The objective measurement of the colour of PRB can help estimating the risk of LGIB 
caused by malignant lesion in patients presenting with PRB, so that we can prioritize 
those high risk patients with PRB to have flexible sigmoidoscopy or colonoscopy 
earlier, especially in those units with long waiting list of endoscopy. Furthermore, the 
use of a standard objective visual aid can assist in history taking for the subjective 
description of the colour of PRB, facilitating decision making for the choice of 
endoscopic investigations. 
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Table 1. Demographic and Clinical Characteristics of Subjects    
       
    Colour of PRB 
  Total (N=293) 1 (N=178) 2 (N=73) 3 (N=26) 4 (N=16) P-value* 
Demographic             
Age (median, IQR) 58 (51-66) 56 (51-65) 58 (50-64) 61 (52-69) 60.5 (55-69.5) 0.275 
Male 153 (52.2%) 81 (45.5%) 40 (54.8%) 18 (69.2%) 14 (87.5%) 0.002 
Smoking Status      0.022 
Smoker 39 (13.3%) 18 (10.1%) 12 (16.4%) 6 (23.1%) 3 (18.8%)  
Non-smoker 203 (69.3%) 137 (77.0%) 45 (61.6%) 12 (46.2%) 9 (56.3%)  
Ex-smoker 51 (17.4%) 23 (12.9%) 16 (21.9%) 8 (30.8%) 4 (25.0%)  
Clinical       
BMI (median, IQR) 
23.6 
(22.0-26.1) 
23.6 
(22.0-26.1) 
24.0 
(22.3-26.7) 
22.0 (26.0-24.3) 23.2 (22.5-26.1) 0.752 
History of colorectal 
neoplasia 
8 (2.7%) 4 (2.2%) 2 (2.7%) 0 (0.0%) 2 (12.5%) 0.084 
Family History of CRC 40 (13.7%) 25 (14.0%) 9 (12.3%) 5 (19.2%) 1 (6.3%) 0.668 
Change of bowel habit      0.001 
No change 253 (86.3%) 155 (87.1%) 67 (91.8%) 22 (84.6%) 9 (56.3%)  
Less frequent 22 (7.5%) 15 (8.4%) 4 (5.5%) 1 (3.8%) 2 (12.5%)  
More frequent 18 (6.1%) 8 (4.5%) 2 (2.7%) 3 (11.5%) 5 (31.3%)  
Change of stool      <0.001 
No change 250 (85.3%) 157 (88.2%) 64 (87.7%) 21 (80.8%) 8 (50.0%)  
Harder stool 16 (5.5%) 11 (6.2%) 5 (6.8%) 0 (0.0%) 0 (0.0%)  
Table
Looser stool 27 (9.2%) 10 (5.6%) 4 (5.5%) 5 (19.2%) 8 (50.0%)  
Significant weight loss 8 (2.7%) 5 (2.8%) 3 (4.1%) 0 (0.0%) 0 (0.0%) 0.636 
Hb level (median, IQR) 
14.0 
(13.0-15.0) 
14.0 
(13.0-15.0) 
14.0 
(13.0-15.0) 
13.0 (15.0-13.5) 14.0 (12.5-15.0) 0.296 
Procedure      <0.001 
Colonoscopy 206 (70.3%) 129 (72.5%) 60 (82.2%) 12 (46.2%) 5 (31.3%)  
Flexible 
sigmodoscopy 
87 (29.7%) 49 (27.5%) 13 (17.8%) 14 (53.8%) 11 (68.8%)   
Note:       
PRB=Per Rectal Bleeding; IQR=Interquartile Range; BMI=Body Mass Index; CRC=Colorectal Cancer  
* Significant difference by Chi-square test or Mann-Whitney U-test, where appropriate   
 
  
Table 2. Diagnosis of Subjects      
       
    Colour of PRB 
  
Total 
(N=293) 
1 (N=178) 2 (N=73) 3 (N=26) 4 (N=16) P-value* 
Diagnosis             
Tumour 17 (5.8%) 4 (2.2%) 2 (2.7%) 7 (26.9%) 4 (25.0%) <0.001 
Advanced neoplastic 
polyp 
11 (3.8%) 2 (1.1%) 2 (2.7%) 3 (11.5%) 4 (25.0%) <0.001 
Polyp size <1cm 78 (26.6%) 46 (25.8%) 20 (27.4%) 5 (19.2%) 7 (43.8%) 0.361  
Colonitis / Proctitis 5 (1.7%) 3 (1.7%) 2 (2.7%) 0 (0.0%) 0 (0.0%) NA 
Pile 
188 
(64.2%) 
125 (70.2%) 48 (65.8%) 12 (46.2%) 3 (18.8%) <0.001 
Others 2 (0.7%) 1 (0.6%) 0 (0.0%) 0 (0.0%) 1 (6.3%) NA 
Distance       
<=10cm 
197 
(67.2%) 
127 (71.3%) 50 (68.5%) 15 (57.7%) 5 (31.3%) 0.008  
>10-20cm 28 (9.6%) 13 (7.3%) 6 (8.2%) 4 (15.4%) 5 (31.3%) 0.012  
>20-60cm 23 (7.8%) 8 (4.5%) 6 (8.2%) 1 (3.8%) 8 (50.0%) <0.001 
>=60cm 4 (1.4%) 3 (1.7%) 0 (0.0%) 0 (0.0%) 1 (6.3%) NA 
Site       
Rectum 
214 
(73.0%) 
136 (76.4%) 52 (71.2%) 19 (73.1%) 7 (43.8%) 0.044  
Rectosigmoid 3 (1.0%) 2 (1.1%) 1 (1.4%) 0 (0.0%) 0 (0.0%) NA 
junction 
Sigmoid colon 48 (16.4%) 25 (14.0%) 12 (16.4%) 6 (23.1%) 5 (31.3%) 0.246  
Descending colon 16 (5.5%) 7 (3.9%) 4 (5.5%) 2 (7.7%) 3 (18.8%) 0.089  
Splenic flexure 1 (0.3%) 1 (0.6%) 0 (0.0%) 0 (0.0%) 0 (0.0%) NA 
Transverse colon 8 (2.7%) 4 (2.2%) 1 (1.4%) 0 (0.0%) 3 (18.8%) <0.001 
Hepatic flexure 1 (0.3%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (6.3%) NA 
Ascending colon 15 (5.1%) 11 (6.2%) 4 (5.5%) 0 (0.0%) 0 (0.0%) 0.441  
Caecum 9 (3.1%) 5 (2.8%) 2 (2.7%) 0 (0.0%) 2 (12.5%) 0.129  
Note:       
PRB=Per Rectal Bleeding      
* Significant difference by Chi-square test     
 
  
Table 3. Performance Characteristics of PRB colour at various cutoff level for 
diagnosis   
        
PRB colour 
cutoff level Sensitivity (%) Specificity (%) PPV (%) NPV (%) 
Positive 
likelihood 
ratio 
Negative 
likelihood 
ratio AUC (95%CI) 
Diagnosis of Tumour or Polyps (n+=102 vs n-=191)       0.610 (0.540-0.681) 
≥2 50.00% 66.49% 44.35% 71.35% 1.492 0.752  
≥3 26.47% 92.15% 64.29% 70.12% 3.371 0.798  
≥4 12.75% 98.43% 81.25% 67.87% 8.114 0.886  
Diagnosis of Tumour or Advanced Neoplastic Polyps (n+=28 vs n-=265)  0.798 (0.695-0.901) 
≥2 78.57% 64.91% 19.13% 96.63% 2.239 0.330  
≥3 64.29% 90.94% 42.86% 96.02% 7.098 0.393  
≥4 28.57% 96.98% 50.00% 92.78% 9.464 0.737  
Diagnosis of Tumour (n+=17 vs n-=276)     0.773 (0.639-0.908) 
≥2 76.47% 63.04% 11.30% 97.75% 2.069 0.373  
≥3 64.71% 88.77% 26.19% 97.61% 5.761 0.398  
≥4 23.53% 95.65% 25.00% 95.31% 5.412 0.799   
Note        
PRB=Per Rectal Bleeding; PPV=Positive predictive value; NPV=Negative predictive value; AUC=Area under ROC curve 
 
  
Table 4. Association between the diagnosis of colonic lesions and colour of PRB 
      
  Logistic Regression 
  Crude OR P-value   Adjusted OR* P-value 
Diagnosis of Tumour or Polyps         
≥2 1.984 (1.215-3.242) 0.006  18.661 (1.994-174.634) 0.010 
≥3 4.224 (2.126-8.393) <0.001  4.749 (0.510-44.252) 0.171 
≥4 9.154 (2.544-32.937) 0.001  0.956 (0.042-21.890) 0.978 
Diagnosis of Tumour or Advanced Neoplastic Polyps  
≥2 6.781 (2.656-17.313) <0.001  6.600 (1.934-22.523) 0.003 
≥3 18.075 (7.501-43.556) <0.001  20.941 (4.726-92.799) <0.001 
≥4 12.850 (4.362-37.856) <0.001  3.408 (0.782-14.848) 0.102 
Diagnosis of Tumour     
≥2 5.544 (1.761-17.457) 0.003  5.362 (1.050-27.387) 0.044 
≥3 14.489 (5.007-41.929) <0.001  17.651 (2.355-132.319) 0.005 
≥4 6.769 (1.918-23.892) 0.003   1.173 (0.150-9.154) 0.879 
Note:      
OR=Odds Ratio     
* Adjusted for demographic, clinical and diagnosis variables in logistic regression 
 
Table 5. Consistency of the colour of PRB reported verbally and by 
colour plate 
     
Verbal \ Colour 
plate number 
1  
(N=166) 
2   
(N=68) 
3   
(N=22) 
4   
(N=15) 
Light Red (N=9) 6 3 0 0 
Fresh Red (N=241) 157 65 13 6 
Dark Red (N=18) 3 0 9 6 
Old Red (N=3) 0 0 0 3 
 
Figure 1.  
Per-rectal bleeding colour card and predicted probabilities of colonic lesion with 
respect to colour 
 
 
 
 
  1 2 3 4 
Tumour or Polyps 0.294 0.304 0.524 0.866 
Tumour or 
Advanced 
Neoplastic Polyps 
0.035 0.074 0.257 0.609 
Tumour 0.025 0.036 0.169 0.345 
 
Note: RBG coding of colour 1 / 2 / 3 / 4 = 24033 / 2141818 / 15600 / 9700. 
Figure 1
Figure 2. 
Receiver operating characteristics curve of PRB colour at various cutoff level for detecting diagnosis of tumour or polyps 
 
 
Figure 2
Figure 3. 
Receiver operating characteristics curve of PRB colour at various cutoff level for detecting diagnosis of tumour or 
advanced neoplastic polyps 
 
 
Figure 3
Figure 4. 
Receiver operating characteristics curve of PRB colour at various cutoff level for detecting diagnosis of tumour 
 
 
 
 
Figure 4
Figure 5. 
Treatment Algorithm 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patient presents with PRB 
Instruct the patient to choose a 
colour from the colour card that is 
best approximate to the colour of PRB 
Observe and follow up  
Instruct the patient to choose a 
colour from the colour card and 
record down on every follow up  
Early colonoscopy 
as soon as possible  
Colour 3 or 4 
Colour 1 or 2 
Previous colonoscopy with 
diagnosis of benign conditions 
only e.g. haemorrhoids   
No 
Routine colonoscopy  
Yes   
Colour 3 or 4 Colour 1 or 2 
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